The structural bases of direct T-cell allorecognition: implications for T-cell-mediated transplant rejection

被引:37
|
作者
Gras, Stephanie [1 ]
Kjer-Nielsen, Lars [2 ]
Chen, Zhenjun [2 ]
Rossjohn, Jamie [1 ]
McCluskey, James [2 ]
机构
[1] Monash Univ, Prot Crystallog Unit, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia
来源
IMMUNOLOGY AND CELL BIOLOGY | 2011年 / 89卷 / 03期
基金
澳大利亚国家健康与医学研究理事会;
关键词
major histocompatibility complex; MHC restriction; allorecognition; X-ray crystallography; MAJOR HISTOCOMPATIBILITY COMPLEX; MHC CLASS-I; EPSTEIN-BARR-VIRUS; RECEPTOR RECOGNITION; CONFORMATIONAL-CHANGES; ANTIGEN RECOGNITION; MOLECULAR MIMICRY; BOUND PEPTIDE; VIRAL PEPTIDE; AMINO-ACIDS;
D O I
10.1038/icb.2010.150
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
alpha beta T-cell receptors (TCRs), which can engage a broad array of foreign peptide-laden major histocompatibility complex (pMHC) landscapes, have an essential role in protective immunity. TCRs are selected by pMHC molecules in the thymus and in the periphery, and so are restricted to recognizing 'self'-major histocompatibility complex (MHC) molecules. Accordingly, T cells are inherently cross-reactive, and although the versatility and specificity of this MHC-restricted response are the hallmarks of adaptive immunity, 'unwanted' TCR interactions, such as those observed in T-cell alloreactivity, often occur. Recent data have shown that direct T-cell alloreactivity can arise from peptide-dependent molecular mimicry, as well as distinct pMHC-binding modes. Here we review recent advances in the field, focusing on structural data pertaining to alloreactivity, and discuss the implications for T-cell-mediated transplant rejection. Immunology and Cell Biology (2011) 89, 388-395; doi:10.1038/icb.2010.150; published online 8 February 2011
引用
收藏
页码:388 / 395
页数:8
相关论文
共 50 条
  • [41] A Molecular Approach to Chronic T-cell Mediated Rejection
    Akalin, Enver
    TRANSPLANTATION, 2018, 102 : S271 - S271
  • [42] T-CELL-MEDIATED ACTIVATION OF MACROPHAGES
    NACY, CA
    MELTZER, MS
    CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (03) : 330 - 335
  • [43] T-CELL-MEDIATED SUPPRESSION OF HEMATOPOIESIS
    MANGAN, KF
    NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (05): : 306 - 307
  • [44] T-CELL-MEDIATED SUPPRESSION OF HEMATOPOIESIS
    BACIGALUPO, A
    MORETTA, L
    IMMUNOLOGY TODAY, 1981, 2 (03): : 47 - 48
  • [45] THE MECHANISM OF T-CELL-MEDIATED LYSIS
    HENNEY, CS
    IMMUNOLOGY TODAY, 1980, 1 (02): : 36 - 41
  • [46] T-cell-mediated control of autoimmunity
    Don Mason
    Arthritis Research & Therapy, 3
  • [47] T-cell-mediated control of autoimmunity
    Mason, D
    ARTHRITIS RESEARCH, 2001, 3 (03) : 133 - 135
  • [48] Aging and T-cell-mediated immunity
    Chakravarti, B
    Abraham, GN
    MECHANISMS OF AGEING AND DEVELOPMENT, 1999, 108 (03) : 183 - 206
  • [49] Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis
    Metzger, Jochen
    Chatzikyrkou, Christos
    Broecker, Verena
    Schiffer, Eric
    Jaensch, Lothar
    Iphoefer, Alexander
    Mengel, Michael
    Mullen, William
    Mischak, Harald
    Haller, Hermann
    Gwinner, Wilfried
    PROTEOMICS CLINICAL APPLICATIONS, 2011, 5 (5-6) : 322 - 333
  • [50] A case of early recurrent immunoglobulin A nephropathy and T-cell-mediated rejection in a transplant patient with Wiskott–Aldrich syndrome
    Kosei Yamaguchi
    Mineaki Kitamura
    Yuki Kawaguchi
    Kanako Hayashi
    Kumiko Muta
    Masayuki Nakazawa
    Tsuyoshi Matsuda
    Toru Onita
    Masaharu Nishikido
    Hideki Sakai
    Hiroshi Mukae
    Tomoya Nishino
    CEN Case Reports, 2022, 11 : 60 - 66